Schedule 13G ownership disclosure
Definium Therapeutics Inc
Common Shares · CUSIP: 24477V105
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Deep Track Capital, LP
Shares: 5,676,540.00 · Class: 5.54%
- Deep Track Biotechnology Master Fund, Ltd.
Shares: 5,676,540.00 · Class: 5.54%
- David Kroin
Shares: 5,676,540.00 · Class: 5.54%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-26-000710
- Form type
- SCHEDULE 13G/A
- Filer
- Deep Track Capital, LP
- CIK
- CIK 1856083
- Filed
- Feb 13, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership